相关实验视频
Updated: Jun 29, 2025

06:09
Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
22.6K
红氧调节LRRK2激酶活性通过活性部位氨酸
Chiara R Trilling1, Jui-Hung Weng2, Pallavi Kaila Sharma2
1Department of Biochemistry, University of Kassel, Kassel, Germany.
NPJ Parkinson's disease
|April 3, 2024
概括
氧化和还原控制了富含白的重复激酶2 (LRRK2) 的活性,这是一种与帕金森病 (PD) 相关的基因. 这种氧化还原调节通过降低LRRK2激酶活性为PD提供了潜在的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生化学
- 结构生物学 结构生物学
背景情况:
- 氨酸丰富的重复激酶2 (LRRK2) 的突变与帕金森病 (PD) 有关.
- LRRK2的激酶域 (KD) 和GTPase域承载着大多数致病突变.
- 在LRRK2的激活段 (AS) 中,一种独特的囊素对 (CC动机) 是其功能的关键.
研究的目的:
- 阐明LRRK2 CC基因 (C2024,C2025) 在调节激酶活性中的作用.
- 研究氧化还原调制对LRRK2功能和微管结合的影响.
- 探索对LRRK2-相关PD的氧化还原剂的治疗潜力.
主要方法:
- 局部定向突变发生以改变氨酸残留物.
- 生物化学测试以测量酶活性.
- 基于细胞的测试和高斯加速分子动力学 (GaMD) 模拟.
- 用降解剂和氧化剂进行处理.
主要成果:
- 氨酸2024 (C2024) 对于LRRK2蛋白激酶活性至关重要.
- 氨酸2025 (C2025) 显著促进了LRRK2.2.的氧化还原敏感性.
- 氧化剂降低LRRK2的激酶活性,特别是在PD相关突变中.
- GaMD模拟揭示了囊素与周围残留物的氧化还原状态依赖相互作用.
结论:
- LRRK2中的CC动机在通过氧化还原机制调节激酶活性方面发挥着关键作用.
- 氧化剂代表了针对帕金森病中过度活跃的LRRK2的有希望的治疗途径.
- 了解半氨酸的作用,为LRRK2调节和PD病变产生提供了洞见.
相关概念视频
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Protein Modifications in the RER
5.2K
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
5.2K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Electron Transport Chain: Complex I and II
13.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.2K
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K

